We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Ultrasonic Screening May Provide More Effective Breast Cancer Detection

By HospiMedica International staff writers
Posted on 21 Mar 2012
Scientists have successfully completed an initial trial of a new, potentially more effective, technique for screening breast cancer using ultrasound. More...


The team, from the National Physical Laboratory (NPL; Teddington, Middlesex, UK), the UK’s National Measurement Institute, working with the University Hospitals Bristol NHS [National Health Service] Foundation Trust, are now looking to develop the technique into a clinical device.

Annually, 46,000 women are diagnosed with breast cancer in the United Kingdom, cutting-edge breast screening methods, based on X-ray mammography. Only approximately 30% of suspicious lesions turn out to be malignant. Each lesion must be confirmed by invasive biopsies, estimated to cost the NHS GBP 35 million per year. Ionizing radiation also has the potential to cause cancer, which limits the use of X-rays to single screenings of at risk groups, such as women over 50 through the National Breast Screening Program.

There is a compelling need to develop improved, ideally nonionizing, methods of detecting breast lesions and solid masses. Improved diagnosis would reduce unnecessary biopsies and consequent patient trauma from being wrongly diagnosed.

Ultrasound fulfills many of the requirements it is safe, low cost, and already extensively used in applications such as fetal scanning. However, the quality of the images is not yet good enough for reliable diagnoses. Part of the difficulty lies with the current detectors used. Different biologic tissues have different sound speeds, and this affects the time taken for sound waves to arrive at the detector. This can distort the arriving waves, in extreme cases causing cancellation them to cancel each other out. This results in imaging errors, such as suggesting abnormal inclusions where there may be none.

The new method works by detecting the intensity of ultrasonic waves. Intensity is converted to heat that is then sensed by a thin membrane of pyroelectric film, which generates a voltage output dependent on the temperature rise. Imaging detectors based on this new principle should be much less susceptible to the effects caused by the uneven sound speed in tissues.

This technique, when used in a computed tomography (CT) configuration, should produce more accurate images of tissue properties and so provide better identification of breast tissue abnormalities. The goal of CT imaging is to generate a cross-section map of the tissue, which defines how the acoustic characteristics vary across the tissue. Using this map, it is possible to identify abnormal inclusions.

An initial feasibility project has proved the theory by testing single detectors using purpose-built artifacts. These artifacts were designed to include well-defined structures, enabling the new imaging technique to be compared with more conventional techniques. The findings validated that the new detectors generated more effective maps of the internal structure of the artifacts than existing techniques.

Having received positive findings and validated the potential of the project, NPL is now seeking funding to develop the work further. They hope to produce a demonstrator using a full array of 20 sensors, which should allow more rapid scanning and move the concept towards a system, which might eventually be used clinically. It is hoped that this will provide both a suitable resolution and fast enough scanning to become a viable replacement for current clinical scanners. Following successful completion of the demonstrator, NPL and partners will look to work with a manufacturer to commercialize the technology.

Dr. Bajram Zeqiri, who leads the project at the National Physical Laboratory, said, “Our initial results are very promising. […] we’re very excited about its potential and with the right funding, support, and industry partners, we may well have something here which could have a huge and positive impact on cancer diagnosis and the lives of many thousands of women.”

Related Links:
UK National Physical Laboratory



Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Infant Incubator
OKM 801
Silver Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.